Susceptibility to exacerbation in COPD JR Hurst, A Anzueto, J Vestbo The Lancet Respiratory Medicine 5 (9), e29, 2017 | 3558 | 2017 |
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a … S Pascoe, N Locantore, MT Dransfield, NC Barnes, ID Pavord The lancet Respiratory medicine 3 (6), 435-442, 2015 | 819 | 2015 |
Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease BR Celli, N Locantore, J Yates, R Tal-Singer, BE Miller, P Bakke, ... American journal of respiratory and critical care medicine 185 (10), 1065-1072, 2012 | 522 | 2012 |
Eosinophilic inflammation in COPD: prevalence and clinical characteristics D Singh, U Kolsum, CE Brightling, N Locantore, A Agusti, R Tal-Singer European Respiratory Journal 44 (6), 1697-1700, 2014 | 504 | 2014 |
Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort NA Hanania, H Müllerova, NW Locantore, J Vestbo, ML Watkins, ... American journal of respiratory and critical care medicine 183 (5), 604-611, 2011 | 449 | 2011 |
Robust principal component analysis for functional data N Locantore, JS Marron, DG Simpson, N Tripoli, JT Zhang, KL Cohen, ... Test 8, 1-73, 1999 | 446 | 1999 |
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD ID Pavord, S Lettis, N Locantore, S Pascoe, PW Jones, JA Wedzicha, ... Thorax 71 (2), 118-125, 2016 | 399 | 2016 |
Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort H Müllerova, DJ Maselli, N Locantore, J Vestbo, JR Hurst, JA Wedzicha, ... Chest 147 (4), 999-1007, 2015 | 398 | 2015 |
New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries N Shrine, AL Guyatt, AM Erzurumluoglu, VE Jackson, BD Hobbs, ... Nature genetics 51 (3), 481-493, 2019 | 374 | 2019 |
Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis BD Hobbs, K De Jong, M Lamontagne, Y Bossé, N Shrine, MS Artigas, ... Nature genetics 49 (3), 426-432, 2017 | 368 | 2017 |
FULFIL trial: once-daily triple therapy for patients with chronic obstructive pulmonary disease DA Lipson, H Barnacle, R Birk, N Brealey, N Locantore, DA Lomas, ... American journal of respiratory and critical care medicine 196 (4), 438-446, 2017 | 362 | 2017 |
Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD DA Lomas, EK Silverman, LD Edwards, NW Locantore, BE Miller, ... European respiratory journal 34 (1), 95-102, 2009 | 314 | 2009 |
Lessons from ECLIPSE: a review of COPD biomarkers R Faner, R Tal-Singer, JH Riley, B Celli, J Vestbo, W MacNee, P Bakke, ... Thorax 69 (7), 666-672, 2014 | 194 | 2014 |
Should we view chronic obstructive pulmonary disease differently after ECLIPSE?. A clinical perspective from the study team J Vestbo, A Agusti, EFM Wouters, P Bakke, PMA Calverley, B Celli, ... American journal of respiratory and critical care medicine 189 (9), 1022-1030, 2014 | 177 | 2014 |
Efficacy and safety of an anti–IL-13 mAb in patients with severe asthma: A randomized trial EH De Boever, C Ashman, AP Cahn, NW Locantore, P Overend, ... Journal of Allergy and Clinical Immunology 133 (4), 989-996. e4, 2014 | 165 | 2014 |
Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis SI Rennard, N Locantore, B Delafont, R Tal-Singer, EK Silverman, ... Annals of the American Thoracic Society 12 (3), 303-312, 2015 | 153 | 2015 |
Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease DD Sin, BE Miller, A Duvoix, SFP Man, X Zhang, EK Silverman, ... American journal of respiratory and critical care medicine 183 (9), 1187-1192, 2011 | 134 | 2011 |
Inflammatory endotype–associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: a multicohort longitudinal analysis Z Wang, N Locantore, K Haldar, MY Ramsheh, AS Beech, W Ma, ... American journal of respiratory and critical care medicine 203 (12), 1488-1502, 2021 | 114 | 2021 |
A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol SJ Pascoe, DA Lipson, N Locantore, H Barnacle, N Brealey, R Mohindra, ... European Respiratory Journal 48 (2), 320-330, 2016 | 96 | 2016 |
Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype BR Celli, N Locantore, R Tal-Singer, J Riley, B Miller, J Vestbo, JC Yates, ... European Respiratory Journal 51 (2), 2018 | 92 | 2018 |